Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2)

Salvatore Modica, Marica Cariello, Annalisa Morgano, Isabelle Gross, Maria Carmela Vegliante, Stefania Murzilli, Lorena Salvatore, Jean Noel Freund, Carlo Sabbà, Antonio Moschetta

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor super-family. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.

Original languageEnglish
Pages (from-to)28421-28432
Number of pages12
JournalJournal of Biological Chemistry
Volume289
Issue number41
DOIs
Publication statusPublished - Oct 10 2014

Fingerprint

Homeobox Genes
Bile Acids and Salts
Intestines
Colorectal Neoplasms
Transcription Factors
Detoxification
Enterocytes
Cytoplasmic and Nuclear Receptors
Carcinogens
Chemical activation
Apoptosis

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology
  • Medicine(all)

Cite this

Modica, S., Cariello, M., Morgano, A., Gross, I., Vegliante, M. C., Murzilli, S., ... Moschetta, A. (2014). Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2). Journal of Biological Chemistry, 289(41), 28421-28432. https://doi.org/10.1074/jbc.M114.571513

Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2). / Modica, Salvatore; Cariello, Marica; Morgano, Annalisa; Gross, Isabelle; Vegliante, Maria Carmela; Murzilli, Stefania; Salvatore, Lorena; Freund, Jean Noel; Sabbà, Carlo; Moschetta, Antonio.

In: Journal of Biological Chemistry, Vol. 289, No. 41, 10.10.2014, p. 28421-28432.

Research output: Contribution to journalArticle

Modica, S, Cariello, M, Morgano, A, Gross, I, Vegliante, MC, Murzilli, S, Salvatore, L, Freund, JN, Sabbà, C & Moschetta, A 2014, 'Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2)', Journal of Biological Chemistry, vol. 289, no. 41, pp. 28421-28432. https://doi.org/10.1074/jbc.M114.571513
Modica, Salvatore ; Cariello, Marica ; Morgano, Annalisa ; Gross, Isabelle ; Vegliante, Maria Carmela ; Murzilli, Stefania ; Salvatore, Lorena ; Freund, Jean Noel ; Sabbà, Carlo ; Moschetta, Antonio. / Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2). In: Journal of Biological Chemistry. 2014 ; Vol. 289, No. 41. pp. 28421-28432.
@article{db0451d5073041b8b9462ffff380eae4,
title = "Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2)",
abstract = "Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor super-family. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.",
author = "Salvatore Modica and Marica Cariello and Annalisa Morgano and Isabelle Gross and Vegliante, {Maria Carmela} and Stefania Murzilli and Lorena Salvatore and Freund, {Jean Noel} and Carlo Sabb{\`a} and Antonio Moschetta",
year = "2014",
month = "10",
day = "10",
doi = "10.1074/jbc.M114.571513",
language = "English",
volume = "289",
pages = "28421--28432",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "41",

}

TY - JOUR

T1 - Transcriptional regulation of the intestinal nuclear bile acid Farnesoid X Receptor (FXR) by the caudal-related homeobox 2 (CDX2)

AU - Modica, Salvatore

AU - Cariello, Marica

AU - Morgano, Annalisa

AU - Gross, Isabelle

AU - Vegliante, Maria Carmela

AU - Murzilli, Stefania

AU - Salvatore, Lorena

AU - Freund, Jean Noel

AU - Sabbà, Carlo

AU - Moschetta, Antonio

PY - 2014/10/10

Y1 - 2014/10/10

N2 - Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor super-family. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.

AB - Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor super-family. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84907637331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907637331&partnerID=8YFLogxK

U2 - 10.1074/jbc.M114.571513

DO - 10.1074/jbc.M114.571513

M3 - Article

C2 - 25138215

AN - SCOPUS:84907637331

VL - 289

SP - 28421

EP - 28432

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 41

ER -